Related Experiment Video
Updated: Jul 11, 2026

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice
Published on: June 28, 2021
"Mechanistic insights into the protective effect of Tongfu Huayu Formula in severe acute pancreatitis: a
Xiwang Wang1, Ying Wang1, Jingjing Jin1
1Department of Gastroenterology, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, 450000, China; Collaborative Innovation Center of Prevention and Treatment of Major Diseases by Chinese and Western Medicine, Zhengzhou, 450000, China.
Background:
Acute pancreatitis involves the self-digestion of pancreatic tissue caused by the abnormal activation of pancreatic enzymes. The disease progresses rapidly, and severe acute pancreatitis (SAP) has a high mortality rate. Currently, there are no satisfactory treatments for SAP. The Tongfu Huayu Formula (TFHYF) is a modified version of the Dachengqi decoction, which has proven to be effective against SAP in clinical research. However, the mechanism of action is unclear.
Purpose:
The aim of this study was to investigate the mechanism and pathways that mediate the protective effect of the TFHYF against SAP in rats using transcriptomic and proteomic techniques.
Methods:
We used ultra-high performance liquid chromatography to identify the main components of the TFHYF, applied Network pharmacology to investigate compound-disease target interaction and used L-arginine to induce SAP in rats. Serum inflammatory factors were detected via enzyme-linked immunosorbent assay, and pathological changes in the pancreatic tissues were evaluated using histochemical staining. Transcriptomic, proteomic analyses and western bolt(WB) were performed to identify potential mechanisms.
Results:
The main components of the TFHYF were determined to be terpenoids, flavonoids, alkaloids, amino acids and their derivatives, coumarins, and phenolic acids. Based on network pharmacological analysis, TNF, STAT3, IL6, AKT1, IL1B, PPARG, etc., were identified as core therapeutic targets. Luteolin, quercetin, and baicalin may represent key bioactive components of TFHYF in treating acute pancreatitis (AP), potentially exerting anti-inflammatory effects on the pancreas by regulating the PI3K-Akt signaling pathway. The histochemical analysis showed that the TFHYF could reduce the degree of pancreatic tissue damage in rats with SAP. ELISA showed that TFHYF could reduce serum levels of AMY2A, IL-6, IL-1β, and TNF-α.Transcriptomic and proteomic analyses demonstrate that TFHYF inhibits pancreatic enzyme secretion and inflammatory responses.
Conclusion:
The findings show that the TFHYF can reduce the severity of SAP in rats by decreasing pancreatic secretion and the levels of inflammatory factors.
More Related Videos
07:10Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct
Published on: April 1, 2022
07:38Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
Related Concept Videos
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Pancreatitis I: Introduction
Acute Pancreatitis II: Pathophysiology
Chronic Pancreatitis II: Pathophysiology